Sonoma Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Revenue	14.29	12.74	13.27	12.63	18.63	Upgrade
Revenue Growth (YoY)	12.20%	-4.05%	5.10%	-32.21%	3.91%	Upgrade
Cost of Revenue	8.82	7.99	8.8	8.64	12.07	Upgrade
Gross Profit	5.47	4.75	4.48	3.99	6.56	Upgrade
Selling, General & Admin	7.36	7.58	8.84	9.76	9.45	Upgrade
Research & Development	1.81	1.87	0.21	0.13	0.56	Upgrade
Operating Expenses	9.18	9.45	9.05	9.88	10.01	Upgrade
Operating Income	-3.71	-4.7	-4.57	-5.89	-3.45	Upgrade
Interest Expense	-	-	-	-0.01	-	Upgrade
Interest & Investment Income	-	-	-	-	0	Upgrade
Currency Exchange Gain (Loss)	0.24	-0.83	-0.69	-0.58	-0.69	Upgrade
Other Non Operating Income (Expenses)	0.56	0.5	0.08	0.19	0.1	Upgrade
EBT Excluding Unusual Items	-2.91	-5.03	-5.18	-6.29	-4.04	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	0.15	0.14	Upgrade
Other Unusual Items	-	-	-	0.72	-	Upgrade
Pretax Income	-2.91	-5.03	-5.18	-5.42	-3.9	Upgrade
Income Tax Expense	0.55	-0.2	-0.03	-0.33	0.71	Upgrade
Earnings From Continuing Operations	-3.46	-4.84	-5.15	-5.09	-4.62	Upgrade
Earnings From Discontinued Operations	-	-	-	-	0.67	Upgrade
Net Income	-3.46	-4.84	-5.15	-5.09	-3.95	Upgrade
Net Income to Common	-3.46	-4.84	-5.15	-5.09	-3.95	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	Upgrade
Shares Change (YoY)	172.75%	168.12%	27.93%	32.92%	35.14%	Upgrade
EPS (Basic)	-2.79	-10.63	-30.35	-38.34	-39.58	Upgrade
EPS (Diluted)	-2.79	-10.63	-30.35	-38.34	-39.58	Upgrade
Free Cash Flow	-0.17	-2.4	-6.42	-4.39	-3.56	Upgrade
Free Cash Flow Per Share	-0.14	-5.28	-37.84	-33.06	-35.64	Upgrade
Gross Margin	38.25%	37.26%	33.73%	31.62%	35.21%	Upgrade
Operating Margin	-25.97%	-36.91%	-34.43%	-46.62%	-18.51%	Upgrade
Profit Margin	-24.20%	-37.97%	-38.81%	-40.28%	-21.20%	Upgrade
Free Cash Flow Margin	-1.18%	-18.85%	-48.38%	-34.72%	-19.09%	Upgrade
EBITDA	-3.57	-4.53	-4.45	-5.7	-3.22	Upgrade
EBITDA Margin	-25.00%	-35.53%	-33.49%	-45.15%	-17.30%	Upgrade
D&A For EBITDA	0.14	0.18	0.13	0.19	0.23	Upgrade
EBIT	-3.71	-4.7	-4.57	-5.89	-3.45	Upgrade
EBIT Margin	-25.97%	-36.91%	-34.43%	-46.62%	-18.51%	Upgrade
Advertising Expenses	0.19	0.16	0.16	0.09	0.04	Upgrade

Updated Jun 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q